Please use this identifier to cite or link to this item: https://doi.org/10.2147/TCRM.S221059
Title: Using patient profiles to guide the choice of antihistamines in the primary care setting in malaysia: Expert consensus and recommendations
Authors: Baharudin, A.
Latiff, A.H.A.
Woo, K.
Yap, F.B.-B.
Tang, I.P.
Leong, K.F.
Chin, W.S.
Wang, D.Y. 
Keywords: Antihistamines
Malaysia
Patient profiling
Primary care
Issue Date: 2019
Publisher: Dove Medical Press Ltd.
Citation: Baharudin, A., Latiff, A.H.A., Woo, K., Yap, F.B.-B., Tang, I.P., Leong, K.F., Chin, W.S., Wang, D.Y. (2019). Using patient profiles to guide the choice of antihistamines in the primary care setting in malaysia: Expert consensus and recommendations. Therapeutics and Clinical Risk Management 15 : 1267-1275. ScholarBank@NUS Repository. https://doi.org/10.2147/TCRM.S221059
Rights: Attribution-NonCommercial 4.0 International
Abstract: H1-antihistamines are recognized to be effective for conditions such as allergic rhinitis and chronic spontaneous urticaria. However, management of such conditions in the real-world primary care setting may be challenging due to diverse patient-specific considerations, the wide range of antihistamines available, choice of other treatment modalities, and the complexity of interpreting specialist treatment algorithms. Despite regular updates to international guidelines, regional/national surveys of healthcare professionals show a clear gap between guidelines and real-world practice, particularly at the primary care level. This article thus presents the consensus opinion of experts from relevant specialties in Malaysia – allergology, pediatrics, otorhinolaryngology, and dermtology – on harmonizing the use and choice of antihistamines in primary care. Patient profiling is recommended as a tool to guide primary care practitioners in prescribing the appropriate antihistamine for each patient. Patient profiling is a three-step approach that involves 1) identifying the individual’s needs; 2) reviewing patient-specific considerations; and 3) monitoring treatment response and referral to specialists in more severe or difficult-to-treat cases. Concurrently, guidelct 3ines should be reviewed and updated periodically to include recommendations that are easily actionable for primary care practitioners. © 2019 Baharudin et al. terms.php and incorporate.
Source Title: Therapeutics and Clinical Risk Management
URI: https://scholarbank.nus.edu.sg/handle/10635/212364
ISSN: 11766336
DOI: 10.2147/TCRM.S221059
Rights: Attribution-NonCommercial 4.0 International
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_2147_TCRM_S221059.pdf1.52 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

5
checked on Sep 22, 2022

Page view(s)

56
checked on Sep 22, 2022

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons